Bluepharma

Bluepharma, established in 2001, is a prominent pharmaceutical group operating within the Healthcare and Pharmaceuticals sectors. With a legacy built on 20 years of innovation and 50 years of experience, the company excels in developing, producing, and commercializing medications across diverse therapeutic areas. Bluepharma provides integrated support throughout the entire product lifecycle, from initial research and development to market launch, ensuring high-quality standards and addressing critical client needs.

The company employs 500 - 1,000 professionals across its operations, managing a presence in 2 locations. Bluepharma's integrated approach extends to specialized services for patients and healthcare professionals, underscoring its commitment to advancing medical solutions. You can Meet Bluepharma's team to understand the leadership driving these initiatives. Their strategic focus includes advancements in oncology through the ONConcept initiative, featuring a new industrial unit for potent oral solid forms, highlighting their commitment to specialized pharmaceutical manufacturing.

Generating substantial revenue, Bluepharma reported $127.7M, positioning it as a significant player. The company's business model encompasses B2B and B2C interactions, facilitated by its integrated services and product development capabilities. Strategic collaborations and investments, such as the ONConcept initiative for oncology treatments, demonstrate a forward-looking strategy aimed at addressing unmet medical needs and expanding its therapeutic reach. Their operational footprint and commitment to quality standards solidify their reputation in the European pharmaceutical landscape.